Calcium channel blockers, beta-blockers and digitalis poisoning: Management in the emergency room

European Review for Medical and Pharmacological Sciences

Volumn 9, Issue 4, 2005, Pages 241-246

  Ojetti, V ^a   Migneco, A ^a   Bononi, F ^a   De Lorenzo, A ^b   Gentiloni Silveri, N ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Antidotes; Beta blockers; Calcium channel blockers; Digitalis; Digoxin specific antibody fragments; Glucagon; Support therapy

Indexed keywords

ACEBUTOLOL; ADRENALIN; AMLODIPINE; ANTIDOTE; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; CARVEDILOL; DIGITALIS; DIGOXIN ANTIBODY; DILTIAZEM; DOBUTAMINE; DOPAMINE; ENOXIMONE; FELODIPINE; GLUCAGON; GLUCOSE; INSULIN; ISOPRENALINE; LABETALOL; METOPROLOL; NIFEDIPINE; NORADRENALIN; PROPRANOLOL; SOTALOL; TIMOLOL; UNINDEXED DRUG; VERAPAMIL;

ARTICLE; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CAUSE OF DEATH; DIGITALIS INTOXICATION; DISEASE SEVERITY; DRUG ERUPTION; DRUG INTOXICATION; DRUG MECHANISM; DRUG OVERDOSE; DRUG PENETRATION; EMERGENCY WARD; HEART ARREST; HEART OUTPUT; HEART VENTRICLE FUNCTION; HUMAN; HYPERGLYCEMIA; HYPOCALCEMIA; HYPOKALEMIA; HYPOTENSION; NAUSEA AND VOMITING; PATIENT MONITORING; PATIENT TRANSPORT; RESUSCITATION; SINUS ARREST; SKIN NECROSIS; STOMACH LAVAGE; SYMPTOMATOLOGY; TORSADE DES POINTES; VASCULAR ACCESS; VASODILATATION;

ADRENERGIC BETA-ANTAGONISTS; ANTIDOTES; CALCIUM CHANNEL BLOCKERS; DIGITALIS; DIGOXIN; EMERGENCY MEDICAL SERVICES; HUMANS;

EID: 23744472166     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Dewitt CR, Waksman JC. Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity. Toxicol Rev 2004; 23: 223-238.
2. Bateman DN. Digoxin-specific antibody fragments: how much and when? Toxicol Rev 2004; 23: 135-143.
3. Luft FC, Haller H. Calcium channel blockers in current medical practice: an update for 1993 Clin Exp Hypertens 1993; 15: 1263-1276.
4. Lubbe WF, Podzuweit T, Opie LH. Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors. J Am Coll Cardiol 1992; 19: 1622-1633
5. Love JN, Litovitz TL, Howell JM, Clancy CJ. Characterization of fatal beta blocker ingestion: a review of the American Association of Poison Control Centers data from 1985 to 1995. Toxicol Clin Toxicol 1997; 35: 353-359.
6. Grossman E, Messerli FH. Calcium antagonists Prog Cardiovasc Dis 2004; 47: 34-57.
7. Magdalan J. New treatment methods in verapamil poisoning: experimental studies. Pol J Pharmacol 2003; 55: 425-432.
8. Luscher TF, Cosentino F. The classification of calcium antagonists and their selection in the treatment of hypertension. A reappraisal Drugs 1998; 55: 509-517.
9. Enyeart JJ, Price WA, Hoffman DA, Woods L. Profound hyperglycemia and metabolic acidosis after verapamil overdose. J Am Coll Cardiol 1983; 2: 1228-1231.
10. Assimes TL, Malcolm I. Torsade de pointes with sotalol overdose treated successfully with lidocaine. Can J Cardiol 1998; 14:753-6.
11. Reith DM, Dawson AH, Epid D, Whyte IM, Buckley NA, Sayer GP. Relative toxicity of beta blockers in overdose. J Toxicol Clin Toxicol 1996; 34: 273-278.
12. Love JN, Howell JM, Litovitz TL, Klein-Schwartz W. Acute beta-blocker overdose: factors associated with the development of cardiovascular morbidity. J Toxicol Clin Toxicol 2000; 38: 275-281.
13. Wax PM, Erdman AR, Chyka PA, et al. Beta-blocker ingestion: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila) 2005; 43: 131-146.
14. European Resuscitation Council. Part 6: advanced cardiovascular life support. Section 7: algorithm approach to ACLS. 7C: a guide to the international ACLS algorithms. European Resuscitation Council. Resuscitation 2000; 46: 169-184.
15. Snook CP, Sigvaldason K, Kristinsson J. Severe atenolol and diltiazem overdose. J Toxicol Clin Toxicol 2000; 38: 661-665.
16. Ashraf M, Chaudhary K, Nelson J, Thompson W. Massive overdose of sustained-release verapamil: a case report and review of literature. Am J Med Sci 1995; 310: 258-263.
17. Kenny J. Treating overdose with calcium channel blockers. BMJ. 1994 16; 308 (6935): 992-993.
18. Roper TA, Sykes R, Gray C. Fatal diltiazem overdose: report of four cases and review of the literature. Postgrad Med J 1993; 69: 474-476.
19. Zimmerman JL. Poisonings and overdoses in the intensive care unit: general and specific management issues. Crit Care Med 2003; 31: 2794-2801
20. Rooney M, Massey KL, JamalI F, Rosin M, Thomson D, Johnson DH. Acebutolol overdose treated with hemodialysis and extracorporeal membrane oxygenation. J Clin Pharmacol 1996; 36: 760-763.
21. Bailey B. Glucagon in beta-blocker and calcium channel blocker overdoses: a systematic review.J Toxicol Clin Toxicol 2003; 41: 595-602.
22. Salhanick SD, Shannon MW. Management of calcium channel antagonist overdose Drug Saf 2003; 26: 65-79.
23. Boyd R, Ghosh A. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Glucagon for the treatment of symptomatic beta blocker overdose.Emerg Med J 2003; 20: 266-267.
24. O'Connor N, Greene S, Dargan P, Jones A Glucagon use in beta blocker overdose. Emerg Med J 2005; 22: 391.
25. Sandroni C, Cavallaro F, Addario C, Ferro G, Gallizzi F, Antonelli M. Successful treatment with enoximone for severe poisoning with atenolol and verapamil: a case report. Acta Anaesthesiol Scand 2004; 48: 790-792.
26. Von Lewinski D, Bruns S, Walther S, Kogler H, Pieske B. Insulin causes [Ca2+]i-dependent and [Ca2+]i-independent positive inotropic effects in failing human myocardium. Circulation 2005; 24; 111: 2588-2595.
27. Megarbane B, Karyo S, Baud FJ. The role of insulin and glucose (hyperinsulinaemia/euglycaemia) therapy in acute calcium channel antagonist and beta-blocker poisoning. Toxicol Rev 2004; 23: 215-222.
28. Mc Millan R. Management of acute severe verapamil intoxication. J Emerg Med 1988; 6:193-196.
29. Howarth DM, Dawson AH, Smith AJ, Buckley N, Whyte IM. Calcium channel blocking drug overdose: an Australian series. Hum Exp Toxicol 1994; 13: 161-166.
30. Donovan KD, Gerace RV, Dreyer JF. Acebutolol-induced ventricular tachycardia reversed with sodium bicarbonate. J Toxicol Clin Toxicol 1999; 37: 481-484
31. Smith TW Pharmacokinetics, bioavailability and serum levels of cardiac glycosides. J Am Coll Cardiol 1985; 5(5 Suppl A): 43A-50A.
32. Hauptman PJ, Kelly RA. Digitalis. Circulation 1999; 99: 1265-1270.
33. + channels: slipmode conductance. Science 1998; 279: 1027-1033.
34. Gittelman MA, Stephan M, Perry H. Acute pediatric digoxin ingestion. Pediatr Emerg Care 1999; 15: 359-362.
35. Ma G, Brady WJ, Pollack M, Chan TC. Electrocardiographic manifestations: digitalis toxicity. J Emerg Med 2001; 20: 145-52.
36. Chen JY, Liu PY, Chen JH, Lin LJ. Safety of transvenous temporary cardiac pacing in patients with accidental digoxin overdose and symptomatic bradycardia. Cardiology 2004; 102: 152-155.
37. Antman EM, Smith TW. Digitalis toxicity. Annu Rev Med 1985; 36: 357-367.
38. Borron SW, Bismuth C, Muszynski J. Advances in the management of digoxin toxicity in the older patient. Drugs Aging 1997; 10: 18-33.
39. Allen NM, Dunham GD. Treatment of digitalis intoxication with emphasis on the clinical use of digoxin immune Fab. DICP 1990; 24: 991-998.
40. Flanagan RJ, Jones AL. Fab antibody fragments: some applications in clinical toxicology. Drug Saf 2004; 27: 1115-1133.